Dingell May Tighten Inspection Provisions In Safety Bill, After Ranbaxy Alert
Executive Summary
House Energy and Commerce Committee Chairman John Dingell, D-Mich., is likely to strengthen FDA mandates proposed in his evolving global drug safety bill, in light of the new Import Alert for more than three dozen Ranbaxy products
You may also be interested in...
Caraco Feels The Sting Of FDA's Accelerated Response To GMP Violations
FDA's fast action to seize drug products and ingredients at three Michigan facilities owned by Caraco Pharmaceutical Laboratories could reflect pressure from Reps. John Dingell and Bart Stupak to tighten controls on generic manufacturers
Caraco Feels The Sting Of FDA's Accelerated Response To GMP Violations
FDA's fast action to seize drug products and ingredients at three Michigan facilities owned by Caraco Pharmaceutical Laboratories could reflect pressure from Reps. John Dingell and Bart Stupak to tighten controls on generic manufacturers
Caraco Seizure Shows FDA's Accelerated Response To GMP Problems
U.S. Marshals swoop into three Michigan facilities three months after FDA's inspection.